SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-11-003926
Filing Date
2011-07-28
Accepted
2011-07-28 16:52:32
Documents
5
Period of Report
2011-07-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k072611_soligenix.htm 8-K 29662
2 AMENDMENT TO THE COLLABORATION AND SUPPLY AGREEMENT f8k072611ex10i_soligenix.htm EX-10.1 90964
3 2011 AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT BETWEEN ENTERON PHARMACEUTICALS, I f8k072611ex10ii_soligenix.htm EX-10.2 23139
4 PRESS RELEASE ISSUED BY SOLIGENIX, INC. ON JULY 28, 2011. f8k072611ex99i_soligenix.htm EX-99.1 31020
5 soligenix.gif GRAPHIC 10021
  Complete submission text file 0001213900-11-003926.txt   190114
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 11994305
SIC: 2834 Pharmaceutical Preparations